Browse by Category:
*These symposia are not supported, endorsed, or accredited by the American College of Chest Physicians, unless otherwise noted.
Featured
Clinical Strategies for Severe Asthma and Chronic Inflammatory Airway Diseases
Convention Center, Room 156
Supported by an educational grant from AstraZeneca Pharmaceuticals.
Pulmonary Hypertension Virtual Patient Encounters: A Patient Simulation Experience
Convention Center, Room 157
Supported by an educational grant from Actelion Pharmaceuticals US, a Janssen Pharmaceutical Company of Johnson & Johnson, Merck & Co. Inc., and United Therapeutics, a public benefit company.
Piecing Together the RSV Mosaic: Patient Narratives to Empower Immunization Efforts
OMNI Hotel, Momentum ABC
Supported by an educational grant from GSK.
Expert-Guided Strategies to Improve Recognition, Diagnosis, and Treatment of PH Associated with ILD
OMNI Hotel, Momentum EFG
Supported by an educational grant from United Therapeutics, a public benefit company.
Understanding Inhibition of Key Cytokines: Explore a Clinical Option for Asthma
Exhibit Hall, Learning Theater 3
Sponsored by Sanofi | Regeneron
Clinical and Patient-Centered Discussions on the Role of Inflammation in Bronchiectasis
Exhibit Hall, Learning Theater 2
Sponsored by Insmed Incorporated
Biomarkers and Drivers of Disease: Why Should You Phenotype Your Patients with Asthma and COPD?
Exhibit Hall, Learning Theater 3
Sponsored by GSK
Recognizing ILD: From Diagnosis to Patient Impact
Exhibit Hall, Learning Theater 1
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
Advances in Managing Chronic Obstructive Lung Disease
Exhibit Hall, Learning Theater 2
Sponsored by Sanofi | Regeneron
The Current State of OFEV® (nintedanib) capsules: Insights for the Healthcare Practitioner
Exhibit Hall, Learning Theater 1
Sponsored by Boehringer Ingelheim Pharmaceuticals, Inc.
A Treatment Option For Multiple Respiratory Diseases
Exhibit Hall, Learning Theater 2
Sponsored by Sanofi | Regeneron
Asthma Drivers of Disease: The Effects of IL-5 on Eosinophils and Other Cell Types That Contribute to Airway Remodeling and Disease Progression
Exhibit Hall, Learning Theater 4
Sponsored by GSK
Pulmonary Alveolar Proteinosis: Pathophysiology, Diagnosis, and Management
Exhibit Hall, Learning Theater 1
Sponsored by Savara
Treatable Traits in COPD: Optimizing Patient Care in an Era of Precision Medicine
Exhibit Hall, Learning Theater 1
Sponsored by Sanofi US Respiratory Medical